Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal


    Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years.

    Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *